Annual Total Debt
$60.58 M
+$19.03 M+45.79%
31 December 2023
Summary:
Rigel Pharmaceuticals annual total debt is currently $60.58 million, with the most recent change of +$19.03 million (+45.79%) on 31 December 2023. During the last 3 years, it has risen by +$21.49 million (+54.99%). RIGL annual total debt is now at all-time high.RIGL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$60.23 M
-$103.00 K-0.17%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly total debt is currently $60.23 million, with the most recent change of -$103.00 thousand (-0.17%) on 30 September 2024. Over the past year, it has dropped by -$570.00 thousand (-0.94%). RIGL quarterly total debt is now -0.94% below its all-time high of $60.80 million, reached on 30 September 2023.RIGL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.8% | -0.9% |
| 3 y3 years | +55.0% | +83.8% |
| 5 y5 years | +100.0% | +57.6% |
RIGL Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +98.2% | -0.9% | +97.0% |
| 5 y | 5 years | at high | -0.9% | +97.0% | |
| alltime | all time | at high | -0.9% |
Rigel Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.23 M(-0.2%) |
| June 2024 | - | $60.33 M(-0.3%) |
| Mar 2024 | - | $60.50 M(-0.1%) |
| Dec 2023 | $60.58 M(+45.8%) | $60.58 M(-0.4%) |
| Sept 2023 | - | $60.80 M(+0.2%) |
| June 2023 | - | $60.67 M(-0.1%) |
| Mar 2023 | - | $60.73 M(+46.2%) |
| Dec 2022 | $41.55 M(+35.9%) | $41.55 M(-2.9%) |
| Sept 2022 | - | $42.78 M(+20.0%) |
| June 2022 | - | $35.65 M(-6.5%) |
| Mar 2022 | - | $38.14 M(+24.8%) |
| Dec 2021 | $30.57 M(-21.8%) | $30.57 M(-6.7%) |
| Sept 2021 | - | $32.77 M(-6.2%) |
| June 2021 | - | $34.94 M(-5.7%) |
| Mar 2021 | - | $37.06 M(-5.2%) |
| Dec 2020 | $39.09 M(+7.6%) | $39.09 M(-4.9%) |
| Sept 2020 | - | $41.10 M(-4.7%) |
| June 2020 | - | $43.12 M(+23.5%) |
| Mar 2020 | - | $34.91 M(-3.8%) |
| Dec 2019 | $36.31 M(>+9900.0%) | $36.31 M(-5.0%) |
| Sept 2019 | - | $38.22 M(+27.0%) |
| June 2019 | - | $30.09 M(-5.1%) |
| Mar 2019 | - | $31.70 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00 | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2011 | - | $134.00 K(-57.5%) |
| June 2011 | - | $315.00 K(-42.6%) |
| Mar 2011 | - | $549.00 K(-31.4%) |
| Dec 2010 | $800.00 K(-58.8%) | $800.00 K(>+9900.0%) |
| Sept 2010 | - | $0.00(-100.0%) |
| June 2010 | - | $1.33 M(-17.8%) |
| Mar 2010 | - | $1.62 M(-16.5%) |
| Dec 2009 | $1.94 M(-42.7%) | $1.94 M(-14.3%) |
| Sept 2009 | - | $2.27 M(-12.7%) |
| June 2009 | - | $2.60 M(-12.1%) |
| Mar 2009 | - | $2.96 M(-12.9%) |
| Dec 2008 | $3.39 M(+91.2%) | $3.39 M(+51.8%) |
| Sept 2008 | - | $2.23 M(+11.2%) |
| June 2008 | - | $2.01 M(+19.8%) |
| Mar 2008 | - | $1.68 M(-5.5%) |
| Dec 2007 | $1.77 M(-24.5%) | $1.77 M(-3.4%) |
| Sept 2007 | - | $1.84 M(-16.4%) |
| June 2007 | - | $2.20 M(-5.1%) |
| Mar 2007 | - | $2.32 M(-1.5%) |
| Dec 2006 | $2.35 M(+6.8%) | $2.35 M(-8.7%) |
| Sept 2006 | - | $2.58 M(-7.9%) |
| June 2006 | - | $2.80 M(+1.0%) |
| Mar 2006 | - | $2.77 M(+25.7%) |
| Dec 2005 | $2.20 M(+4.8%) | $2.20 M(+10.0%) |
| Sept 2005 | - | $2.00 M(-11.7%) |
| June 2005 | - | $2.27 M(-14.0%) |
| Mar 2005 | - | $2.64 M(+25.5%) |
| Dec 2004 | $2.10 M(-39.9%) | $2.10 M(-4.7%) |
| Sept 2004 | - | $2.21 M(-8.0%) |
| June 2004 | - | $2.40 M(-16.9%) |
| Mar 2004 | - | $2.89 M(-17.4%) |
| Dec 2003 | $3.50 M(-38.7%) | $3.50 M(-13.2%) |
| Sept 2003 | - | $4.03 M(-13.7%) |
| June 2003 | - | $4.66 M(-5.8%) |
| Mar 2003 | - | $4.95 M(-13.2%) |
| Dec 2002 | $5.70 M(-23.1%) | $5.70 M(-14.8%) |
| Sept 2002 | - | $6.69 M(-6.7%) |
| June 2002 | - | $7.17 M(+1.8%) |
| Mar 2002 | - | $7.04 M(-5.0%) |
| Dec 2001 | $7.41 M(-18.6%) | $7.41 M(-7.2%) |
| Sept 2001 | - | $7.99 M(-8.9%) |
| June 2001 | - | $8.77 M(+4.4%) |
| Mar 2001 | - | $8.40 M(-7.8%) |
| Dec 2000 | $9.11 M(+19.1%) | $9.11 M(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00 |
| Dec 1999 | $7.65 M | - |
FAQ
- What is Rigel Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual total debt year-on-year change?
- What is Rigel Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly total debt year-on-year change?
What is Rigel Pharmaceuticals annual total debt?
The current annual total debt of RIGL is $60.58 M
What is the all time high annual total debt for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual total debt is $60.58 M
What is Rigel Pharmaceuticals annual total debt year-on-year change?
Over the past year, RIGL annual total debt has changed by +$19.03 M (+45.79%)
What is Rigel Pharmaceuticals quarterly total debt?
The current quarterly total debt of RIGL is $60.23 M
What is the all time high quarterly total debt for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly total debt is $60.80 M
What is Rigel Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, RIGL quarterly total debt has changed by -$570.00 K (-0.94%)